Fabros, Jullian Mae .
HRN: 26-87-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/29/2025
04/08/2025
IV
70mg
Q8h
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes